FATE
Fate Therapeutics Inc
NASDAQ: FATE · HEALTHCARE · BIOTECHNOLOGY
$2.14
-6.20% today
Updated 2026-06-02
Market cap
$230.79M
P/E ratio
—
P/S ratio
36.54x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$1 – $3
Volume
2.9M
Fate Therapeutics Inc (FATE) Insider transactions
Net insider activity
Net buying (0 shares)
Buy transactions
0
Sell transactions
0
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|